The emergence of bacterial resistance has motivated researchers to discover new
antibacterial agents. Nowadays, fluoroquinolones keep their status as one of the essential …

Many adverse reactions to therapeutic drugs appear to be allergic in nature, and are thought
to be triggered by patient-specific Immunoglobulin E (IgE) antibodies that recognize the drug …

For the optimization of dosing regimens of anti-infective agents, it is imperative to have a
good understanding of pharmacokinetics (PK) and pharmacodynamics (PD). Whenever …

Background Chronic bacterial prostatitis (CBP) is frequently diagnosed in men of fertile age,
and is characterized by a disabling array of symptoms, including pain in the pelvic area (for …

Objectives The prostatitis syndrome is classified into bacterial prostatitis (acute and chronic),
chronic pelvic pain syndrome and asymptomatic prostatitis. The aim of this report is to review …

We previously demonstrated the safety and efficacy of fluoroquinolone–macrolide
combination therapy in category II chronic bacterial prostatitis (CBP). The aim of this study is …

В обзоре на основе собственных и литературных данных рассмотрены молекулярные
и метаболические предпосылки развития идиопатического бесплодия у мужчин …

Cancer is a disease without limits turning out to be prime cause for raising death toll around
the world. Several treatment strategies including chemotherapy, surgery and radiotherapy …

Levofloxacin is a broad-spectrum fluoroquinolone used in the treatment of both acute and
chronic bacterial prostatitis. Currently, the treatment of bacterial prostatitis is still difficult …

Chronic bacterial prostatitis (CBP) is a persistent infection of the prostate characterized by
poor quality of life mainly due to frequent relapse episodes caused by incomplete …